Literature DB >> 15199326

Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters.

Krishnan Bhaskaran1, Deenan Pillay, A Sarah Walker, Martin Fisher, David Hawkins, Richard Gilson, Ken McLean, Kholoud Porter.   

Abstract

Using data from the UK Register of HIV Sero-converters, we compared the rate of CD4 cell decline in antiretroviral-naive individuals with and without evidence of transmitted drug resistance (TDR). Although there was a suggestion that CD4 cell decline in the first year after seroconversion was faster in those with TDR,there was no evidence of a difference in the rate of decline thereafter. The virological and host determinants of this possible phenomenon are worth further exploration.

Entities:  

Mesh:

Year:  2004        PMID: 15199326     DOI: 10.1097/01.aids.0000131341.45795.33

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have sex with men in Seattle/King County, WA, 2005-2007.

Authors:  Susan E Buskin; Giovanina M Ellis; Gregory G Pepper; Lisa M Frenkel; Steven A Pergam; Geoffrey S Gottlieb; Carrie Horwitch; Jeffrey F Olliffe; Karen Johnson; Peter Shalit; Corinne Heinen; Margot Schwartz; Robert W Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

2.  Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.

Authors:  Theppharit Panichsillapakit; Davey M Smith; Joel O Wertheim; Douglas D Richman; Susan J Little; Sanjay R Mehta
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

3.  X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI.

Authors:  Jade Ghosn; Julie Galimand; Stéphanie Raymond; Laurence Meyer; Christiane Deveau; Cécile Goujard; Jacques Izopet; Christine Rouzioux; Marie-Laure Chaix
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

4.  Transmitted human immunodeficiency virus-1 drug resistance in a cohort of men who have sex with men in Belo Horizonte, Brazil--1996-2012.

Authors:  Unaí Tupinambás; Helena Duani; Ana Virgínia Cunha Martins; Agdemir Waleria Aleixo; Dirceu Bartolomeu Greco
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-06       Impact factor: 2.743

5.  Prevalence of and viral outcomes associated with primary HIV-1 drug resistance.

Authors:  S E Buskin; S Zhang; C S Thibault
Journal:  Open AIDS J       Date:  2012-09-07

6.  Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients.

Authors:  Kristof Theys; Koen Deforche; Jurgen Vercauteren; Pieter Libin; David Amc van de Vijver; Jan Albert; Birgitta Asjö; Claudia Balotta; Marie Bruckova; Ricardo J Camacho; Bonaventura Clotet; Suzie Coughlan; Zehava Grossman; Osamah Hamouda; Andrzei Horban; Klaus Korn; Leondios G Kostrikis; Claudia Kücherer; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Elisabeth Puchhammer-Stockl; Chiara Riva; Lidia Ruiz; Kirsi Liitsola; Jean-Claude Schmit; Rob Schuurman; Anders Sönnerborg; Danica Stanekova; Maja Stanojevic; Daniel Struck; Kristel Van Laethem; Annemarie Mj Wensing; Charles Ab Boucher; Anne-Mieke Vandamme
Journal:  Retrovirology       Date:  2012-10-03       Impact factor: 4.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.